Brief: Kala Announces Entry Into Definitive Agreement To Sell Eysuvis And Inveltys To Alcon

KALA BIO

23/05/2022 05:14

May 23 (Reuters) - Kala Pharmaceuticals Inc  KALA.O :
    * KALA ANNOUNCES ENTRY INTO DEFINITIVE AGREEMENT TO SELL
EYSUVIS®
AND INVELTYS® TO ALCON INC.
    * KALA PHARMACEUTICALS - KALA WILL RECEIVE AN UPFRONT
PAYMENT OF
$60 MILLION AND WILL BE ELIGIBLE TO RECEIVE COMMERCIAL-BASED
SALES MILESTONE PAYMENTS
    * ANTICIPATES TRANSACTION WILL CLOSE IN Q3 OF 2022

Source text for Eikon:  ID:nGNXcbhMg9 
Further company coverage:  KALA.O 

 ((Reuters.Briefs@thomsonreuters.com;))